Longwood Capital Partners »

Aclaris Therapeutics shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $834k 122k 6.85
2023-06-30 $1.3M 122k 10.37
2023-03-31 $986k 122k 8.09
2022-12-31 $4.0M 255k 15.75
2022-09-30 $2.5M 161k 15.74
2022-06-30 $2.7M 193k 13.96
2022-03-31 $3.8M 218k 17.24
2021-12-31 $1.4M 98k 14.54
2021-09-30 $2.5M 141k 18.00
2021-06-30 $3.1M 175k 17.56
2021-03-31 $8.0M 318k 25.20
2017-12-31 $2.3M 93k 24.66
2017-06-30 $2.4M 90k 27.12
2017-03-31 $6.0M 200k 29.82
2016-12-31 $10M 373k 27.14